The idea to establish Kure It came after Barry Hoeven was diagnosed with kidney cancer in 1998 while on a family vacation. Over the past 12 years Barry and his family have been battling this disease. He has had several operations, including both a radical and partial nephrectomy, and is currently on the medication Sutent to control the current growth of tumors which have metastasized to his lungs.
Very soon after diagnosis, Barry began to compile information about his cancer including speaking with prominent specialists in the field. He recognized early on that there is a grave disconnect between the amount of people afflicted with kidney cancer and the amount of funding and research being conducted to find a cure. It became clear to him that more research needed to be done.
In April of 2007, Barry partnered with City of Hope to create a fund called Kure It! Kidney Cancer Research Fund, which raised over $400,000 with the help of friends, family and colleagues. In January 2010, all involved determined the time had come to establish Kure It, Inc. as an independent non-profit 501(c)(3) organization; allowing for a broader range of opportunities resulting in a greater impact.
Kure It’s goal is to be the leader in granting funds to kidney and other cancer researchers conducting innovative research projects to better treat and ultimately cure kidney and other orphan cancers.
The mission of Kure It is to provide direct funding for innovative kidney and other orphan cancer research. The money raised through Kure It will directly support researchers who are committed to finding long-term treatments, and ultimately a cure for cancer.